You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ALOCRIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Alocril patents expire, and what generic alternatives are available?

Alocril is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in ALOCRIL is nedocromil sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nedocromil sodium profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ALOCRIL?
  • What are the global sales for ALOCRIL?
  • What is Average Wholesale Price for ALOCRIL?
Summary for ALOCRIL
Drug patent expirations by year for ALOCRIL
Drug Prices for ALOCRIL

See drug prices for ALOCRIL

Pharmacology for ALOCRIL
Drug ClassMast Cell Stabilizer
Physiological EffectDecreased Histamine Release

US Patents and Regulatory Information for ALOCRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ALOCRIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 ⤷  Sign Up ⤷  Sign Up
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 ⤷  Sign Up ⤷  Sign Up
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ALOCRIL

See the table below for patents covering ALOCRIL around the world.

Country Patent Number Title Estimated Expiration
France 2563105 COMPOSITIONS POUR LES SOINS DES VOIES RESPIRATOIRES ⤷  Sign Up
Japan 2504926 ⤷  Sign Up
France 2609392 COMPOSITIONS PHARMACEUTIQUES CONTENANT DES PYRANOQUINOLEINES ⤷  Sign Up
Spain 8707222 PROCEDIMIENTO PARA LA OBTENCION DEL 9-ETIL-4,6-DIOXO-10-PROPIL-6,9-DIHIDRO-4H-PIRANO(3,2-G)QUINOLINA-2,8-DICARBOXILATO DE DIETILO (Process for obtaining diethyl 9-ethyl-4,6-dioxo-10-propyl- 6,9-dihydro-4H-pyrano[3,2-g]quinolene-2,8-dicarboxylate Process for obtaining diethyl 9-ethyl-4,6-dioxo-10-propyl- 6,9-dihydro-4H-pyrano[3,2-g]quinolene-2,8-dicarboxylate) ⤷  Sign Up
Japan H01199909 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRANOQUINOLINE DERIVATIVE ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.